Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,483
archived clinical trials in
Influenza

Study of VIS410 in Subjects With Uncomplicated Influenza A
A Phase 2a Double-blind, Placebo-controlled Study to Assess the Safety and Tolerability of a Single Intravenous Dose of VIS410 in Subjects With Uncomplicated Influenza A Infection
Status: Enrolling
Updated:  12/13/2017
1357
mi
from 91732
Houston, TX
Study of VIS410 in Subjects With Uncomplicated Influenza A
A Phase 2a Double-blind, Placebo-controlled Study to Assess the Safety and Tolerability of a Single Intravenous Dose of VIS410 in Subjects With Uncomplicated Influenza A Infection
Status: Enrolling
Updated: 12/13/2017
Clinical Research Facility
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Study of VIS410 in Subjects With Uncomplicated Influenza A
A Phase 2a Double-blind, Placebo-controlled Study to Assess the Safety and Tolerability of a Single Intravenous Dose of VIS410 in Subjects With Uncomplicated Influenza A Infection
Status: Enrolling
Updated:  12/13/2017
1297
mi
from 91732
McAllen, TX
Study of VIS410 in Subjects With Uncomplicated Influenza A
A Phase 2a Double-blind, Placebo-controlled Study to Assess the Safety and Tolerability of a Single Intravenous Dose of VIS410 in Subjects With Uncomplicated Influenza A Infection
Status: Enrolling
Updated: 12/13/2017
Clinical Research Facility
1297
mi
from 91732
McAllen, TX
Click here to add this to my saved trials
Study of VIS410 in Subjects With Uncomplicated Influenza A
A Phase 2a Double-blind, Placebo-controlled Study to Assess the Safety and Tolerability of a Single Intravenous Dose of VIS410 in Subjects With Uncomplicated Influenza A Infection
Status: Enrolling
Updated:  12/13/2017
6677
mi
from 91732
Asenovgrad,
Study of VIS410 in Subjects With Uncomplicated Influenza A
A Phase 2a Double-blind, Placebo-controlled Study to Assess the Safety and Tolerability of a Single Intravenous Dose of VIS410 in Subjects With Uncomplicated Influenza A Infection
Status: Enrolling
Updated: 12/13/2017
6677
mi
from 91732
Asenovgrad,
Click here to add this to my saved trials
The Effect of Proximity on Flu-Shot Participation
The Effect of Proximity on Flu-Shot Participation
Status: Enrolling
Updated:  12/14/2017
1567
mi
from 91732
Saint Louis, MO
The Effect of Proximity on Flu-Shot Participation
The Effect of Proximity on Flu-Shot Participation
Status: Enrolling
Updated: 12/14/2017
Express Scripts
1567
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Testing the AVI-7100 Flu Drug in Healthy Volunteers
A Phase 1, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of AVI-7100 in Healthy Subjects
Status: Enrolling
Updated:  12/22/2017
2277
mi
from 91732
Bethesda, MD
Testing the AVI-7100 Flu Drug in Healthy Volunteers
A Phase 1, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of AVI-7100 in Healthy Subjects
Status: Enrolling
Updated: 12/22/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
2277
mi
from 91732
Bethesda, MD
Click here to add this to my saved trials
The Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101)
A Phase IA/IB Trial to Evaluate the Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101) With Hemagglutinin Dose Escalation Compared to Non-Adjuvanted Comparator Inactivated Influenza Vaccine (IIV) Standard Dose (SD) in Healthy Adults and High Dose (HD) IIV in Ambulatory Elderly Subjects
Status: Enrolling
Updated:  1/26/2018
1566
mi
from 91732
Saint Louis, MO
The Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101)
A Phase IA/IB Trial to Evaluate the Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101) With Hemagglutinin Dose Escalation Compared to Non-Adjuvanted Comparator Inactivated Influenza Vaccine (IIV) Standard Dose (SD) in Healthy Adults and High Dose (HD) IIV in Ambulatory Elderly Subjects
Status: Enrolling
Updated: 1/26/2018
Saint Louis University School of Medicine
1566
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Clinical Performance of the Diassess Influenza A and B Test
Clinical Performance of the Diassess Influenza A and B Test
Status: Enrolling
Updated:  2/2/2018
2319
mi
from 91732
Syracuse, NY
Clinical Performance of the Diassess Influenza A and B Test
Clinical Performance of the Diassess Influenza A and B Test
Status: Enrolling
Updated: 2/2/2018
University Health Care Center
2319
mi
from 91732
Syracuse, NY
Click here to add this to my saved trials
The Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine
Clinical Immunization Safety Assessment (CISA): A Study to Assess the Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine (IIV) Administered to Children 6 Through 47 Months of Age
Status: Enrolling
Updated:  2/5/2018
2202
mi
from 91732
Durham, NC
The Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine
Clinical Immunization Safety Assessment (CISA): A Study to Assess the Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine (IIV) Administered to Children 6 Through 47 Months of Age
Status: Enrolling
Updated: 2/5/2018
Duke University Health System
2202
mi
from 91732
Durham, NC
Click here to add this to my saved trials
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated:  2/5/2018
2480
mi
from 91732
Milford, CT
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
2480
mi
from 91732
Milford, CT
Click here to add this to my saved trials
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated:  2/5/2018
2318
mi
from 91732
Coral Gables, FL
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
2318
mi
from 91732
Coral Gables, FL
Click here to add this to my saved trials
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated:  2/5/2018
1182
mi
from 91732
Wichita, KA
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
1182
mi
from 91732
Wichita, KA
Click here to add this to my saved trials
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated:  2/5/2018
2245
mi
from 91732
Rochester, NY
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
2245
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated:  2/5/2018
2560
mi
from 91732
Warwick, RI
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
2560
mi
from 91732
Warwick, RI
Click here to add this to my saved trials
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated:  2/5/2018
1763
mi
from 91732
Nashville, TN
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
1763
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated:  2/5/2018
570
mi
from 91732
Salt Lake City, UT
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
570
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated:  2/5/2018
561
mi
from 91732
West Jordan, UT
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
561
mi
from 91732
West Jordan, UT
Click here to add this to my saved trials
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated:  2/5/2018
1573
mi
from 91732
Saint Louis, MO
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
1573
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry Protocol
Status: Enrolling
Updated:  2/5/2018
105
mi
from 91732
San Diego, CA
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry Protocol
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
105
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry Protocol
Status: Enrolling
Updated:  2/5/2018
2321
mi
from 91732
Miami, FL
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry Protocol
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
2321
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry Protocol
Status: Enrolling
Updated:  2/5/2018
2437
mi
from 91732
Albany, NY
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry Protocol
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
2437
mi
from 91732
Albany, NY
Click here to add this to my saved trials
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry Protocol
Status: Enrolling
Updated:  2/5/2018
2375
mi
from 91732
Philadelphia, PA
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry Protocol
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry Protocol
Status: Enrolling
Updated:  2/5/2018
1763
mi
from 91732
Nashville, TN
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry Protocol
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
1763
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
207
mi
from 91732
Fresno, CA
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
207
mi
from 91732
Fresno, CA
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
21
mi
from 91732
Long Beach, CA
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
21
mi
from 91732
Long Beach, CA
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
328
mi
from 91732
Stanford, CA
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
328
mi
from 91732
Stanford, CA
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
2305
mi
from 91732
Atlantis, FL
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
2305
mi
from 91732
Atlantis, FL
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
2321
mi
from 91732
Miami, FL
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
2321
mi
from 91732
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
1729
mi
from 91732
Chicago, IL
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
1729
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
1966
mi
from 91732
Detroit, MI
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
1966
mi
from 91732
Detroit, MI
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
1962
mi
from 91732
Royal Oak, MI
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
1962
mi
from 91732
Royal Oak, MI
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
1964
mi
from 91732
Troy, MI
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
1964
mi
from 91732
Troy, MI
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
1511
mi
from 91732
Minneapolis, MN
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
1511
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
1573
mi
from 91732
Saint Louis, MO
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
1573
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
2431
mi
from 91732
Teaneck, NJ
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
2431
mi
from 91732
Teaneck, NJ
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
2126
mi
from 91732
Winston-Salem, NC
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
2126
mi
from 91732
Winston-Salem, NC
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
1357
mi
from 91732
Houston, TX
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
7213
mi
from 91732
Cairns,
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
7213
mi
from 91732
Cairns,
Click here to add this to my saved trials
PregText: Feasibility of Monitoring Influenza Vaccine Safety in Pregnant Women Using Text Messaging
PregText: Assessing the Feasibility of Monitoring Influenza Vaccine Safety in Pregnant Women Using Text Messaging
Status: Enrolling
Updated:  2/12/2018
2435
mi
from 91732
New York, NY
PregText: Feasibility of Monitoring Influenza Vaccine Safety in Pregnant Women Using Text Messaging
PregText: Assessing the Feasibility of Monitoring Influenza Vaccine Safety in Pregnant Women Using Text Messaging
Status: Enrolling
Updated: 2/12/2018
Columbia University
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
Kent State University / Price Chopper Employee Wellness Study
Kent State University / Price Chopper Wellness Promotion Study
Status: Enrolling
Updated:  2/27/2018
mi
from 91732
Schenectady, NY
Kent State University / Price Chopper Employee Wellness Study
Kent State University / Price Chopper Wellness Promotion Study
Status: Enrolling
Updated: 2/27/2018
The Golub Corporation (Price Chopper / Market 32)
mi
from 91732
Schenectady, NY
Click here to add this to my saved trials
H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults
A Phase I Randomized, Double-Blind, Controlled Trial in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of a Monovalent Inactivated Influenza A/H5N8 Virus Vaccine Administered Intramuscularly at Different Dosages Given With or Without AS03 or MF59 Adjuvants
Status: Enrolling
Updated:  3/1/2018
1528
mi
from 91732
Iowa City, IA
H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults
A Phase I Randomized, Double-Blind, Controlled Trial in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of a Monovalent Inactivated Influenza A/H5N8 Virus Vaccine Administered Intramuscularly at Different Dosages Given With or Without AS03 or MF59 Adjuvants
Status: Enrolling
Updated: 3/1/2018
University of Iowa - Vaccine Research & Education Unit
1528
mi
from 91732
Iowa City, IA
Click here to add this to my saved trials
H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults
A Phase I Randomized, Double-Blind, Controlled Trial in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of a Monovalent Inactivated Influenza A/H5N8 Virus Vaccine Administered Intramuscularly at Different Dosages Given With or Without AS03 or MF59 Adjuvants
Status: Enrolling
Updated:  3/1/2018
1571
mi
from 91732
Saint Louis, MO
H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults
A Phase I Randomized, Double-Blind, Controlled Trial in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of a Monovalent Inactivated Influenza A/H5N8 Virus Vaccine Administered Intramuscularly at Different Dosages Given With or Without AS03 or MF59 Adjuvants
Status: Enrolling
Updated: 3/1/2018
Saint Louis University - Center for Vaccine Development
1571
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults
A Phase I Randomized, Double-Blind, Controlled Trial in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of a Monovalent Inactivated Influenza A/H5N8 Virus Vaccine Administered Intramuscularly at Different Dosages Given With or Without AS03 or MF59 Adjuvants
Status: Enrolling
Updated:  3/1/2018
1880
mi
from 91732
Cincinnati, OH
H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults
A Phase I Randomized, Double-Blind, Controlled Trial in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of a Monovalent Inactivated Influenza A/H5N8 Virus Vaccine Administered Intramuscularly at Different Dosages Given With or Without AS03 or MF59 Adjuvants
Status: Enrolling
Updated: 3/1/2018
Cincinnati Children's Hospital Medical Center - Infectious Diseases
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults
A Phase I Randomized, Double-Blind, Controlled Trial in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of a Monovalent Inactivated Influenza A/H5N8 Virus Vaccine Administered Intramuscularly at Different Dosages Given With or Without AS03 or MF59 Adjuvants
Status: Enrolling
Updated:  3/1/2018
1357
mi
from 91732
Houston, TX
H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults
A Phase I Randomized, Double-Blind, Controlled Trial in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of a Monovalent Inactivated Influenza A/H5N8 Virus Vaccine Administered Intramuscularly at Different Dosages Given With or Without AS03 or MF59 Adjuvants
Status: Enrolling
Updated: 3/1/2018
Baylor College of Medicine - Molecular Virology and Microbiology
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
1784
mi
from 91732
Birmingham, AL
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
1784
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
1546
mi
from 91732
Harrisburg, AR
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
1546
mi
from 91732
Harrisburg, AR
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
11
mi
from 91732
Downey, CA
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
11
mi
from 91732
Downey, CA
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
15
mi
from 91732
Paramount, CA
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
15
mi
from 91732
Paramount, CA
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
105
mi
from 91732
San Diego, CA
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
105
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
2321
mi
from 91732
Miami, FL
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
2321
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
664
mi
from 91732
Meridian, ID
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
664
mi
from 91732
Meridian, ID
Click here to add this to my saved trials